Michael Anthony Marella
32Patents
11h-index
44Co-inventors
75Inventor score
Filing activity: Feb 5, 1997 → Nov 12, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7317037B2 | Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof | Human Necessities | 60 | Expired |
| US5688955A | Kappa agonist compounds and pharmaceutical formulations thereof | Chemistry; Metallurgy | 40 | Expired |
| US9346738B2 | Process for the preparation of treprostinil and derivatives thereof | Emerging Cross-Sectional Technologies | 34 | Active |
| US6486165B2 | Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith | Chemistry; Metallurgy | 32 | Expired |
| US5763445A | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith | Emerging Cross-Sectional Technologies | 29 | Expired |
| US5981513A | Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith | Emerging Cross-Sectional Technologies | 26 | Expired |
| US5744458A | Kappa agonist compounds and pharmaceutical formulations thereof | Chemistry; Metallurgy | 24 | Expired |
| US6303611A | Kappa agonist compounds and pharmaceutical formulations thereof | Chemistry; Metallurgy | 23 | Expired |
| US6057323A | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith | Chemistry; Metallurgy | 21 | Expired |
| US6054445A | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritis therewith | Chemistry; Metallurgy | 20 | Expired |
| US6492351B1 | Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith | Chemistry; Metallurgy | 17 | Expired |
| US5945443A | Kappa agonist compounds and pharmaceutical formulations thereof | Chemistry; Metallurgy | 11 | Expired |
| US6028063A | Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6180623A | Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6239154A | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith | Chemistry; Metallurgy | 6 | Expired |
| US7517899B2 | Phenylaminopropanol derivatives and methods of their use | Chemistry; Metallurgy | 3 | Active |
| US10252918B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | Emerging Cross-Sectional Technologies | 3 | Active |
| US6391910B1 | Kappa agonist compounds and pharmaceutical formulations thereof | Chemistry; Metallurgy | 3 | Expired |
| US7618990B2 | Oxazolidone derivatives as PR modulators | Chemistry; Metallurgy | 2 | Active |
| US7601722B2 | Aryl sulfamide derivatives and methods of their use | Chemistry; Metallurgy | 1 | Active |
| US10710889B2 | EMM-31 materials and processes and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US7294647B2 | Kappa agonist compounds and pharmaceutical formulations thereof | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6960612B2 | Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7652018B2 | Imidazolidin-2-one derivatives useful as PR modulators | Chemistry; Metallurgy | 0 | Active |
| US7538107B2 | Oxazinan-2-one derivatives useful as PR modulators | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.